Back to Database
Status published
Medium
CVE-2017-17678
BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting...
Vulnerability Description
BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.
Impact Analysis
Refer to official advisory for detailed impact metrics.
Remediation
Ensure systems are updated to the latest vendor-supplied patch levels.
THREAT MONITOR
Am I Vulnerable?
Launch our assessment wizard to check if your infrastructure is exposed to • CVE-2017-17678
Credits & Attribution
No credits recorded in the NVD database.
References
More from bmc
View All →CVE-2022-26088
An issue was discovered in BMC Remedy before 22.1. Email-based...
Unknown
0
CVE-2020-35593
BMC PATROL Agent through 20.08.00 allows local privilege escalation via...
High
7.8
CVE-2019-8352
By default, BMC PATROL Agent through 11.3.01 uses a static...
Critical
9.8
CVE-2019-17044
An issue was discovered in BMC Patrol Agent 9.0.10i. Weak...
High
7.8
CVE-2019-17043
An issue was discovered in BMC Patrol Agent 9.0.10i. Weak...
High
7.8
Affected Vendor
Affected Software
remedy mid-tier
Vulnerable Versions:
9.1
Timeline
Official Publish:
May 19th, 2021
Last Modified:
July 9th, 2026
Added to House:
July 20th, 2026
CVSS Vectors
V3:
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
Weaknesses (CWE)
No CWE data available
MITRE ATT&CK TTPs
No associated TTPs found for this vulnerability.